ID
40761
Description
Study ID: 101468/218 Clinical Study ID: SKF-101468/218 Study Title:A Single-Blind, Randomised, Placebo-Controlled, Parallel-Group, Multicentre, Phase IIa Study to Determine the Pharmacokinetics and Tolerability of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Sponsor: GlaxoSmithKline Phase: phase 2 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: requip Study Indication: Restless Legs Syndrome
Mots-clés
Versions (1)
- 08/05/2020 08/05/2020 -
Détendeur de droits
GlaxoSmithKline
Téléchargé le
8 mai 2020
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Pharmacokinetics and Tolerability of Ropinirole in Patients Suffering from Restless Legs Syndrome 101468/218
Pregnancy Information; Study Conclusion, Investigator's Statement (Follow-Up)
Description
Pregnancy Information
Alias
- UMLS CUI-1
- C0032961
- UMLS CUI-2
- C1533716
Description
Study Conclusion
Alias
- UMLS CUI-1
- C1707478
- UMLS CUI-2
- C0008972
Description
Did the subject complete the study as planned?
Type de données
boolean
Alias
- UMLS CUI [1]
- C2348577
Description
If the subject did not complete the study as planned, mark the most appropriate category
Type de données
integer
Alias
- UMLS CUI [1,1]
- C2348577
- UMLS CUI [1,2]
- C2826287
Description
Other reason for not completing the study as planned
Type de données
text
Alias
- UMLS CUI [1,1]
- C2348577
- UMLS CUI [1,2]
- C2826287
- UMLS CUI [1,3]
- C0205394
Description
Comments on reason for withdrawal:
Type de données
text
Alias
- UMLS CUI [1,1]
- C0947611
- UMLS CUI [1,2]
- C2349954
- UMLS CUI [1,3]
- C0566251
Description
Date of Withdrawal:
Type de données
date
Alias
- UMLS CUI [1,1]
- C2349954
- UMLS CUI [1,2]
- C0011008
Description
Time of Withdrawal:
Type de données
time
Alias
- UMLS CUI [1,1]
- C2349954
- UMLS CUI [1,2]
- C0040223
Description
Date of Final Dose:
Type de données
date
Alias
- UMLS CUI [1]
- C1762893
Description
Time of Final Dose:
Type de données
time
Alias
- UMLS CUI [1]
- C0946444
Description
Investigator's Statement
Alias
- UMLS CUI-1
- C0008961
- UMLS CUI-2
- C1710187
Description
Check all Adverse Event forms are up to date and complete
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0920316
- UMLS CUI [1,3]
- C0205197
Description
Check that the Concomitant Medication form is up to date
Type de données
integer
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C0920316
- UMLS CUI [1,3]
- C0237400
Description
Check that all appropriate pages are signed (thus indicating completion) and dated
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0805732
- UMLS CUI [1,2]
- C1283174
Description
Check that laboratory results are included
Type de données
integer
Alias
- UMLS CUI [1,1]
- C1254595
- UMLS CUI [1,2]
- C0920316
Description
I certify that the observations and findings are recorded correctly and completely in this CRF.
Type de données
text
Alias
- UMLS CUI [1]
- C2346576
Description
Investigator's Signature Date
Type de données
date
Alias
- UMLS CUI [1,1]
- C2346576
- UMLS CUI [1,2]
- C0011008
Similar models
Pregnancy Information; Study Conclusion, Investigator's Statement (Follow-Up)
C0019994 (UMLS CUI [1,2])
C2826287 (UMLS CUI [1,2])
C2826287 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C2349954 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
C1710187 (UMLS CUI-2)
C0920316 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,3])
C0920316 (UMLS CUI [1,2])
C0237400 (UMLS CUI [1,3])
C1283174 (UMLS CUI [1,2])
C0920316 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])